Novel (3 + 1)-dimensional variable-coefficients Boussinesq-type equation: exploring integrability, Wronskian, and Grammian solutions
Physica Scripta · 01.12.2024 · 99 (12) · 125250
DOI: 10.1088/1402-4896/ad8d3e ↗Kurz gefasst
Fachartikel in der Zeitschrift Physica Scripta, online erschienen am 18.11.2024. Verfasst von Majid Madadi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
In this paper, we introduce a novel (3 + 1)-dimensional variable-coefficients Boussinesq-type equation. We analyze its integrability using the Painlevé test and the N -soliton solution, demonstrating that both tests yield identical conditions. Using the Hirota bilinear form of the equation, we derive Wronskian and Grammian determinant solutions utilizing Plücker relations and the Jacobi identity for determinants. In particular, we use elementary transformation and long wave limit to get the determinant expression of m th-order lump solutions from the 2 m th-order Wronskian determinant solutions. Furthermore, we reveal a variety of novel semi-rational solutions using the Hirota method and Grammian determinant techniques.
Zitieren
APA
Madadi, M., Asadi, E., & Inc, M. (2024). Novel (3 + 1)-dimensional variable-coefficients Boussinesq-type equation: exploring integrability, Wronskian, and Grammian solutions. Physica Scripta, 99(12), 125250. https://doi.org/10.1088/1402-4896/ad8d3e
Vancouver
Madadi M, Asadi E, Inc M. Novel (3 + 1)-dimensional variable-coefficients Boussinesq-type equation: exploring integrability, Wronskian, and Grammian solutions. Physica Scripta. 2024;99(12):125250. doi:10.1088/1402-4896/ad8d3e
BibTeX
@article{Madadi2024,
author = {Madadi, Majid and Asadi, Esmaeel and Inc, Mustafa},
title = {Novel (3 + 1)-dimensional variable-coefficients Boussinesq-type equation: exploring integrability, Wronskian, and Grammian solutions},
journal = {Physica Scripta},
year = {2024},
volume = {99},
number = {12},
pages = {125250},
doi = {10.1088/1402-4896/ad8d3e}
}
EUVIMED